Back
Kiniksa Pharmaceuticals Vs. Amicus Therapeutics Industry Stock Comparison
Buy
58
KNSA
Kiniksa Pharmaceuticals
Last Price:
17.88
Seasonality Move:
4.08%
Sell
25
FOLD
Amicus Therapeutics
Last Price:
10.28
Seasonality Move:
21.11%
Buy
58
Kiniksa Pharmaceuticals (KNSA)
is a Buy
Is Kiniksa Pharmaceuticals a Buy, Sell or Hold?
- The current Kiniksa Pharmaceuticals [KNSA] share price is $17.88. The Score for KNSA is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- KNSA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
25
Amicus Therapeutics (FOLD)
is a Sell
Is Amicus Therapeutics a Buy, Sell or Hold?
- The current Amicus Therapeutics [FOLD] share price is $10.28. The Score for FOLD is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
- FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
KNSA Stock Price Chart
What is Kiniksa Pharmaceuticals's stock price today?
-
The Kiniksa Pharmaceuticals share price today is $17.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNSA is experiencing slight buying pressure.
FOLD Stock Price Chart
What is Amicus Therapeutics's stock price today?
-
The Amicus Therapeutics share price today is $10.28
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing buying pressure, which is a positive indicator for future bullish movement.
KNSA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.48 | Sell |
| Relative Strength Index (14 RSI): | 46.17 | Sell |
| Chaikin Money Flow: | 142673 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.1 - 19.2) | Sell |
| Bollinger Bands (100): | (17.63 - 20.03) | Sell |
FOLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 33.84 | Sell |
| Chaikin Money Flow: | 1060549 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.57 - 11.63) | Sell |
| Bollinger Bands (100): | (11.31 - 13.47) | Sell |
KNSA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.36 | Buy |
| 20-day SMA: | 17.71 | Buy |
| 50-day SMA: | 19.23 | Sell |
| 200-day SMA: | 17.72 | Buy |
| 8-day EMA: | 17.58 | Buy |
| 20-day EMA: | 17.89 | Sell |
| 50-day EMA: | 18.53 | Sell |
| 200-day EMA: | 17.54 | Buy |
FOLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.51 | Sell |
| 20-day SMA: | 10.97 | Sell |
| 50-day SMA: | 11.92 | Sell |
| 200-day SMA: | 12.21 | Sell |
| 8-day EMA: | 10.52 | Sell |
| 20-day EMA: | 10.91 | Sell |
| 50-day EMA: | 11.56 | Sell |
| 200-day EMA: | 12.02 | Sell |
Kiniksa Pharmaceuticals Earnings Growth & KNSA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $0.23 per share.
Amicus Therapeutics Earnings Growth & FOLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and an increase next year of $0.38 per share.
Kiniksa Pharmaceuticals Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Amicus Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||